Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

Trial Profile

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PG 2 (Primary)
  • Indications Fatigue
  • Focus Therapeutic Use
  • Sponsors PhytoHealth

Most Recent Events

  • 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
  • 01 Aug 2017 Status changed from recruiting to completed.
  • 09 May 2017 Planned number of patients changed from 250 to 350.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top